Viewing Study NCT00570492


Ignite Creation Date: 2025-12-24 @ 3:38 PM
Ignite Modification Date: 2026-02-25 @ 5:53 PM
Study NCT ID: NCT00570492
Status: COMPLETED
Last Update Posted: 2017-09-15
First Post: 2007-12-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study.
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rhinitis, Allergic, Perennial View
Keywords:

Keywords

Keyword Brief Keyword Text View
None allergic rhinitis View
None fluticasone furoate nasal spray View
None growth View